scispace - formally typeset
U

Umar Mahmood

Researcher at Harvard University

Publications -  221
Citations -  19114

Umar Mahmood is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & In vivo. The author has an hindex of 54, co-authored 207 publications receiving 17286 citations. Previous affiliations of Umar Mahmood include Fox Chase Cancer Center & Cornell University.

Papers
More filters
Journal ArticleDOI

Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions

TL;DR: The clinical translation of OMI to percutaneous hepatic interventions was demonstrated and ICG was found to localize with TBRs greater than 2.0 (median, 7.9; range, 2.4-13.4) in all target lesions.
Journal ArticleDOI

Coded aperture nuclear scintigraphy: a novel small animal imaging technique.

TL;DR: Coded aperture nuclear scintigraphy works best for images where activity is concentrated in small volumes; a low count outline may be better demonstrated using conventional collimator imaging, so CA imaging should be viewed as a technique to complement rather than replace traditional nuclear imaging methods.
Journal ArticleDOI

Development of a Time Domain Fluorimeter for Fluorescent Lifetime Multiplexing Analysis

TL;DR: A portable, inexpensive USB-powered time domain fluorimeter (TDF) and analysis scheme were developed for use in evaluating a new class of fluorescent lifetime multiplexed dyes.
Journal ArticleDOI

Interventional Optical Molecular Imaging Guidance during Percutaneous Biopsy

TL;DR: The custom-designed molecular imaging device, in combination with ICG, readily allowed differentiation between normal and malignant tissue in a murine model of intrahepatic colorectal metastasis in a mouse model.
Journal ArticleDOI

RSNA International Trends: A Global Perspective on the COVID-19 Pandemic and Radiology in Late 2020.

TL;DR: Experiences from radiology experts in representative countries from around the world are detail to help address management challenges as cases continue to rise in many parts of the world and suggest modifications in workflow that are likely to continue after this pandemic subsides.